Phased-Array Versus Curvilinear Probe for FAST Ultrasonography
NCT ID: NCT07037797
Last Updated: 2025-06-26
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
NOT_YET_RECRUITING
NA
2660 participants
INTERVENTIONAL
2025-07-01
2027-05-02
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
FAST ultrasound is a crucial technique in emergency medicine, enabling rapid assessment of trauma patients.
By allowing visualization of an effusion in a trauma patient in a far more sensitive and specific way than clinical examination, it enables informed decisions to be made on therapeutics, technical gestures, but also the potential receiving service.
Arbitrarily, FAST ultrasound is taught with the cardiac probe (phased-array) and the abdominal probe (curvilinear). The difference in use of these two probes varies according to operator and team, with no figures available.
No recent study has been conducted on the possibility of better diagnostic performance of FAST with a curvilinear versus phased-array probe.
Objective:
The main objective of this project is to evaluate and compare the diagnostic performance of FAST ultrasound using a phased-array probe versus a curvilinear probe in the detection of effusions in trauma patients (FAST protocol).
Materials and methods:
Prospective, interventional, multicenter, randomized study.
Hypothesis tested:
FAST-ultrasound with a curvilinear probe improves diagnostic performance compared with FAST-ultrasound with a phased-array probe.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Ultrasound Guided Vascular Access in Pediatric Intensive Care Patients
NCT00207883
Robot-based Tele-echography II - A Comparative Study
NCT00295438
Daily Ultrasound-screening for CVC-related Thrombosis
NCT03327376
Ultrasound-Guided Peripheral Intravenous Access by Critical Nurses.
NCT02285712
Gastric Ultrasound Feeding Tube Placement Confirmation Study
NCT06595537
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
DIAGNOSTIC
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Curvilinear probe then phased-array probe
The first probe used is the curvilinear following by the phased-array probe
Order of the FAST echography
Randomisation of the order in which probes are used
Phased-array probe then curvilinear probe
The first probe used is the phased-array probe following by the curvilinear probe
Order of the FAST echography
Randomisation of the order in which probes are used
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Order of the FAST echography
Randomisation of the order in which probes are used
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Age ≥ 18 years
* Indication retained for FAST-ultrasound by the emergency physician in charge of the patient
* Patient affiliated to the French Social Security system or equivalent
Exclusion Criteria
* Pregnant, parturient or breast-feeding women
* Patients deprived of liberty by judicial or administrative decision
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Centre Hospitalier Memorial France Etats-Unis
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Félix AMIOT, MD
Role: PRINCIPAL_INVESTIGATOR
Hopital Mémorial France Etats-Unis - Urgences/SAMU/SMUR
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2024-A00914-43
Identifier Type: OTHER
Identifier Source: secondary_id
RC-2024-001
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.